Coherus Oncology, Inc.

CHRS · XNAS

CIK 1512762fmd_1AKC87E1HWGQ2SPEEACG7D60BBManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2012 to Sep 30, 2026, 56 periods

Ratios computed from the standardized statements. Select a value to open its proof.